CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

12 hedge funds and large institutions have $132K invested in COSCIENS Biopharma Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

93% less call options, than puts

Call options by funds: $226K | Put options by funds: $3.05M

94% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 18

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$226K
Puts
$3.05M
Net Calls
Net Calls Change

Top Buyers

1
+$6.69K
2
+$2K
3
+$1.05K

Top Sellers

1
-$37K
2
-$35K
3
-$20K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$18K
5
VF
Virtu Financial
New York
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$53K
2
$35K
3
$19.8K
4
$15K
5
$2K
6
$2K
7
$2K
8
$1K
9
$1K
10
$1K
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2